Volatile Anesthetics Regulate Anti-Cancer Relevant Signaling
- PMID: 33718164
- PMCID: PMC7952859
- DOI: 10.3389/fonc.2021.610514
Volatile Anesthetics Regulate Anti-Cancer Relevant Signaling
Abstract
Volatile anesthetics are widely used inhalation anesthetics in clinical anesthesia. In recent years, the regulation of anti-cancer relevant signaling of volatile anesthetics has drawn the attention of investigators. However, their underlying mechanism remains unclear. This review summarizes the research progress on the regulation of anti-cancer relevant signaling of volatile anesthetics, including sevoflurane, desflurane, xenon, isoflurane, and halothane in vitro, in vivo, and clinical studies. The present review article aims to provide a general overview of regulation of anti-cancer relevant signaling and explore potential underlying molecular mechanisms of volatile anesthetics. It may promote promising insights of guiding clinical anesthesia procedure and instructing enhance recovery after surgery (ERAS) with latent benefits.
Keywords: anti-cancer; inhalation anesthesia; mechanism; volatile anesthesia; volatile anesthetics.
Copyright © 2021 Wang, Cheng, Lu, Sun and Huang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
